UA83245C2 - Regioselective synthesis of cci-779 - Google Patents

Regioselective synthesis of cci-779

Info

Publication number
UA83245C2
UA83245C2 UAA200602447A UAA200602447A UA83245C2 UA 83245 C2 UA83245 C2 UA 83245C2 UA A200602447 A UAA200602447 A UA A200602447A UA A200602447 A UAA200602447 A UA A200602447A UA 83245 C2 UA83245 C2 UA 83245C2
Authority
UA
Ukraine
Prior art keywords
cci
regioselective synthesis
regioselective
synthesis
boronate
Prior art date
Application number
UAA200602447A
Other languages
English (en)
Ukrainian (uk)
Inventor
Уоррен Чью
Чиа-Ченг Шо
Original Assignee
Уайт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уайт filed Critical Уайт
Publication of UA83245C2 publication Critical patent/UA83245C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

Предлагается способ региоселективного синтеза ССІ-779, основанный на химии боронатов. Также предложены новые промежуточные продукты, которые применяются в данном способе.
UAA200602447A 2003-08-07 2004-07-15 Regioselective synthesis of cci-779 UA83245C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49324903P 2003-08-07 2003-08-07
PCT/US2004/022860 WO2005016935A2 (en) 2003-08-07 2004-07-15 Regioselective synthesis of cci-779

Publications (1)

Publication Number Publication Date
UA83245C2 true UA83245C2 (en) 2008-06-25

Family

ID=34193170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200602447A UA83245C2 (en) 2003-08-07 2004-07-15 Regioselective synthesis of cci-779

Country Status (26)

Country Link
US (1) US7153957B2 (ru)
EP (1) EP1658295B1 (ru)
JP (1) JP4227649B2 (ru)
KR (1) KR20060057605A (ru)
CN (1) CN1829722B (ru)
AR (1) AR045217A1 (ru)
AT (1) ATE365169T1 (ru)
AU (1) AU2004265267A1 (ru)
BR (1) BRPI0412667A (ru)
CA (1) CA2532988A1 (ru)
CO (1) CO5650251A2 (ru)
CR (1) CR8189A (ru)
DE (1) DE602004007145T2 (ru)
DK (1) DK1658295T3 (ru)
EC (1) ECSP066413A (ru)
ES (1) ES2287772T3 (ru)
IL (1) IL173134A0 (ru)
MX (1) MXPA06000951A (ru)
NO (1) NO20060494L (ru)
PL (1) PL1658295T3 (ru)
PT (1) PT1658295E (ru)
RU (1) RU2339639C2 (ru)
TW (1) TW200508241A (ru)
UA (1) UA83245C2 (ru)
WO (1) WO2005016935A2 (ru)
ZA (1) ZA200601055B (ru)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389209B1 (en) * 2001-04-24 2009-04-08 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
WO2003097647A1 (en) * 2002-05-15 2003-11-27 Endocyte, Inc. Vitamin-mitomycin conjugates
NZ537829A (en) 2002-07-30 2006-09-29 Wyeth Corp Parenteral formulations containing a rapamycin hydroxyester
DK1592457T3 (da) 2003-01-27 2012-10-22 Endocyte Inc Folat-vinblastin-konjugat som lægemiddel
RU2345999C2 (ru) * 2003-09-03 2009-02-10 Уайт Аморфный 42-эфир рапамицина и 3-гидрокси-2(гидроксиметил)-2-метилпропионовой кислоты и содержащие его фармацевтические композиции
JP2007517879A (ja) * 2004-01-08 2007-07-05 ワイス Ｃｃｉ−７７９経口投与用の直接圧縮可能な医薬組成物
JP4224115B2 (ja) 2004-04-14 2009-02-12 ワイス ラパマイシン４２−エステル誘導体の位置特異的合成
AU2005238432A1 (en) 2004-04-14 2005-11-10 Wyeth Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
AU2005233612A1 (en) 2004-04-14 2005-10-27 Wyeth Proline CCI-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline CCI-779 and CCI-779 using microbial lipase
CA2562164A1 (en) * 2004-04-27 2005-11-10 Wyeth Labeling of rapamycin using rapamycin-specific methylases
JP5149620B2 (ja) 2004-07-23 2013-02-20 エンドサイト，インコーポレイテッド ２価リンカーおよびその結合体
MX2007001676A (es) * 2004-08-10 2007-04-12 Wyeth Corp Derivados de 42-ester de rapamicina con acido 2,2-bis(hidroximetil)propionico y metodos para hacer los mismos.
KR20070070184A (ko) 2004-10-28 2007-07-03 와이어쓰 자궁근종의 치료에 있어서 ｍＴＯＲ 억제제의 용도
CA2595766A1 (en) * 2005-02-09 2006-08-17 Wyeth Cci-779 polymorph and use thereof
CA2599580A1 (en) 2005-03-02 2006-09-08 Wyeth Recovery of cci-779 from mother liquors
JP2008531686A (ja) 2005-03-02 2008-08-14 ワイス ラパマイシンの精製
EP1863816B1 (en) 2005-03-16 2014-06-25 Endocyte, Inc. Synthesis and purification of pteroic acid and conjugates thereof
AU2006279304A1 (en) 2005-08-19 2007-02-22 Endocyte, Inc. Multi-drug ligand conjugates
EP2382995A3 (en) * 2005-08-19 2013-09-25 Endocyte, Inc. Ligand conjugates of Vinca alkaloids, analogs and derivatives
WO2007056175A2 (en) * 2005-11-04 2007-05-18 Wyeth 41-methoxy isotope labeled rapamycin 42-ester
JP2009514870A (ja) 2005-11-04 2009-04-09 ワイス ｍＴＯＲインヒビター、ハーセプチン、および／またはＨＫＩ−２７２の抗悪性腫瘍性組み合わせ
AR058282A1 (es) * 2005-12-07 2008-01-30 Wyeth Corp Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
BRPI0619592A2 (pt) * 2005-12-07 2016-09-06 Wyeth Corp métodos para medir a qualidade da partícula de um composto de rapamicina, para determinar o tamanho de partícula médio de uma amostra e a cristalinidade de um composto de rapamicina, e para a purificação de rapamicina
US7622578B2 (en) * 2005-12-07 2009-11-24 Wyeth Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
RU2008121713A (ru) * 2005-12-20 2010-01-27 Вайет (Us) Контроль стабильности лекарственной формы cci-779 посредством контроля примесей лекарственныхого вещества
US20070203169A1 (en) * 2006-02-28 2007-08-30 Zhao Jonathon Z Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
WO2008101231A2 (en) 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
CN104127878A (zh) * 2007-03-14 2014-11-05 恩多塞特公司 结合配体连接的微管溶素递药缀合物
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
TW200901989A (en) 2007-04-10 2009-01-16 Wyeth Corp Anti-tumor activity of CCI-779 in papillary renal cell cancer
BRPI0812970A2 (pt) * 2007-06-25 2019-09-24 Endocyte Inc conjugados contendo espaçadores hidrofílicos
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
US9187521B2 (en) 2007-10-25 2015-11-17 Endocyte, Inc. Tubulysins and processes for preparing
WO2011051960A2 (en) 2009-09-25 2011-05-05 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
AU2011210227A1 (en) * 2010-01-28 2012-08-30 Fresenius Kabi Oncology Ltd. Process for the preparation of Temsirolimus and its intermediates
CN102020662B (zh) * 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔制备方法
CN102020661B (zh) * 2011-01-07 2013-02-13 天津市炜杰科技有限公司 一种驮瑞塞尔合成方法
MX2013011412A (es) * 2011-04-01 2014-04-30 Sandoz Ag Acilacion regioselectiva de rapamicina en la posicion c-42.
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
EP2908818A4 (en) 2012-10-16 2016-07-13 Endocyte Inc CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
CN104086564B (zh) * 2014-07-30 2019-02-05 江苏奥赛康药业股份有限公司 一种高纯度坦罗莫司的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
DE19857765A1 (de) 1998-12-15 2000-06-21 Clariant Gmbh Verfahren zur Herstellung von para-Oxadiazolyl-phenyl-boronsäuren
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives

Also Published As

Publication number Publication date
US7153957B2 (en) 2006-12-26
PL1658295T3 (pl) 2007-11-30
RU2339639C2 (ru) 2008-11-27
ZA200601055B (en) 2008-07-30
TW200508241A (en) 2005-03-01
ECSP066413A (es) 2006-09-18
CA2532988A1 (en) 2005-02-24
HK1085482A1 (en) 2006-08-25
EP1658295A2 (en) 2006-05-24
JP4227649B2 (ja) 2009-02-18
ATE365169T1 (de) 2007-07-15
AR045217A1 (es) 2005-10-19
CN1829722B (zh) 2010-10-27
NO20060494L (no) 2006-03-06
CN1829722A (zh) 2006-09-06
BRPI0412667A (pt) 2006-09-26
DK1658295T3 (da) 2007-09-24
US20050033046A1 (en) 2005-02-10
EP1658295B1 (en) 2007-06-20
DE602004007145T2 (de) 2008-02-28
MXPA06000951A (es) 2006-03-30
AU2004265267A1 (en) 2005-02-24
KR20060057605A (ko) 2006-05-26
PT1658295E (pt) 2007-09-25
IL173134A0 (en) 2006-06-11
WO2005016935A3 (en) 2005-04-07
RU2006106910A (ru) 2007-09-20
DE602004007145D1 (de) 2007-08-02
ES2287772T3 (es) 2007-12-16
WO2005016935A2 (en) 2005-02-24
JP2007501783A (ja) 2007-02-01
CR8189A (es) 2006-10-04
CO5650251A2 (es) 2006-06-30

Similar Documents

Publication Publication Date Title
TW200508241A (en) Regioselective synthesis of CCI-779
EP1668628A4 (en) METHOD FOR SYNTHESIZING SPEECH
SG152239A1 (en) Compounds for proteasome enzyme inhibition
SG145694A1 (en) Novel compounds
TW200512191A (en) Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
WO2004078757A3 (en) Synthesis of 5-substituted 7-azaindoles and 7-azaidonines
IL182698A0 (en) Bivalirudin
AU2003294691A1 (en) Method for producing leather
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
AU2002221587A1 (en) Method for tanning of hides by means of tanning agents
ZA200306568B (en) High-pressure fischer-tropsch synthesis process using an optimized coolant
ZA200604357B (en) Method of performing electrochemical reaction
SG142306A1 (en) Methods for neuroprotection
AU2003244165A1 (en) Charger for portable telephone
TW200420530A (en) Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
AU2003282630A1 (en) Process for anaerobic oxidation of methane
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
AU2003276825A1 (en) Method of immunotherapy
AU2003293639A1 (en) Technical process for isolating homoeriodictyol
GB0321978D0 (en) New method of producing cell cultures
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
IL175528A0 (en) Methods of preparing compounds useful as protease inhibitors
MXPA05009152A (es) Preparacion de k-252a.
AU2003241614A1 (en) Method for quantitating negative strand rna synthesis
SG141216A1 (en) Method of forming cosix